FDA Approves Anifrolumab (Saphnelo) as New Lupus Treatment ...Middle East

Medscape - News
Anifrolumab, a monoclonal antibody against type 1 interferon receptor, improved overall disease activity in patients with SLE on standard therapy, according to data from three trials. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Anifrolumab (Saphnelo) as New Lupus Treatment )

Apple Storegoogle play

Also on site :